Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 137, 2017 - Issue 8
Submit an article Journal homepage
403
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Utility of clinico-biological data for long-term prognosis of head and neck terminal cancer

Taiji KawasakiDepartment of Otorhinolaryngology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan; Correspondence[email protected]
,
Koichiro WasanoDepartment of Otorhinolaryngology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan; ;Department of Otorhinolaryngology, Head and Neck Surgery, Keio University, School of Medicine, Tokyo, Japan
,
Sayuri YamamotoDepartment of Otorhinolaryngology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan;
,
Shuta TomisatoDepartment of Otorhinolaryngology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan;
&
Kaoru OgawaDepartment of Otorhinolaryngology, Head and Neck Surgery, Keio University, School of Medicine, Tokyo, Japan
Pages 895-898 | Received 03 Jan 2017, Accepted 09 Feb 2017, Published online: 16 Mar 2017

References

  • Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. The global burden of cancer 2013. JAMA Oncol 2015;1:505–27.
  • Morita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index: A scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 1999;7:128–33.
  • Maltoni M, Nanni O, Pirovano M, Scarpi E, Indelli M, Martini C, et al. Successful validation of the Palliative Prognostic Score in terminally ill cancer patients. J Pain Sympt Manage 1999;17:240–7.
  • Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008;359:1116–27.
  • Iro H, Waldfahrer F. Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients. Cancer 1998;15:2201–7.
  • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–55.
  • Kang SH, Cho KH, Park JW, Yoon KW, Do JY. Onodera's prognostic nutritional index as a risk factor for mortality in peritoneal dialysis patients. J Korean Med Sci 2012;27:1354–8.
  • McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007;22:881–6.
  • Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008;34:55–60.
  • Kowalski LP, Carvalho AL. Natural history of untreated head and neck cancer. Eur J Cancer 2000;36:1032–7.
  • Takenaka Y, Takemoto N, Nakahara S, Yamamoto Y, Yasui T, Hanamoto A, et al. Prognostic significance of body mass index before treatment for head and neck cancer. Head Neck 2015;37:1518–23.
  • Kubrak C, Olson K, Jha N, Jensen L, McCargar L, Seikaly H, et al. Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck 2010;32:290–300.
  • de Carvalho TM, Miguel Marin D, da Silva CA, de Souza AL, Talamoni M, Lima CS, Monte Alegre S. Evaluation of patients with head and neck cancer performing standard treatment in relation to body composition, resting metabolic rate, and inflammatory cytokines. Head Neck 2015;37:97–102.
  • Dewys WD, Beqq C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69:491–7.
  • Roxburgh CS, Mcmillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 2014;110:1409–12.
  • Richey LM, George JR, Couch ME, Kanapkey BK, Yin X, Cannon T, et al. Defining cancer cachexia in head and neck squamous cell carcinoma. Clin Cancer Res 2007;13:6561–7.
  • Nakayama M, Tabuchi K, Hara A. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer. Head Neck 2015;37:1745–9.
  • Kono T, Sakamoto K, Shinden S, Ogawa K. Pre-therapeutic nutritional assessment for predicting severe adverse events in patients with head and neck cancer treated by radiotherapy. Clin Nutr 2016 [5 Nov];[1–5]. DOI:10.1016/j.clnu.2016.10.021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.